Skip to content
Magnolia Market Access
  • Our ExpertiseExpand
    • Policy & Access
    • Pricing & Value
    • RWE & HEOR
    • Commercialization & Analytics
  • Our WorkExpand
    • Insights
    • Events
    • Market Access Briefs
  • Meet Our Team
  • Meet MKG
Contact Us
Magnolia Market Access

Real World Evidence (RWE) & Market Analytics

Linking EMR With SDOH Data: Insights Across Disease Cohorts

Linking EMR With SDOH Data: Insights Across Disease Cohorts

AMCP Spring 2024 Platinum Poster.

Read More Linking EMR With SDOH Data: Insights Across Disease CohortsContinue

Social Determinants of Health in a Real-World Adult HIV Population: ICD-10-CM and Consumer Linked Data Identification

Social Determinants of Health in a Real-World Adult HIV Population: ICD-10-CM and Consumer Linked Data Identification

AMCP Spring 2024.

Read More Social Determinants of Health in a Real-World Adult HIV Population: ICD-10-CM and Consumer Linked Data IdentificationContinue

Learnings from Linking Closed Claims Patient Cohorts with Consumer SDOH Data

Learnings from Linking Closed Claims Patient Cohorts with Consumer SDOH Data

ISPOR Spring 2024.

Read More Learnings from Linking Closed Claims Patient Cohorts with Consumer SDOH DataContinue

Using payer and age mix as the basis for developing a go-to-market strategy for a prelaunch drug

Using payer and age mix as the basis for developing a go-to-market strategy for a prelaunch drug

A biopharma company prepping to launch a biosimilar needed to know payer segments and patient age demographics.

Read More Using payer and age mix as the basis for developing a go-to-market strategy for a prelaunch drugContinue

Using published evidence and compendia to support expanded coverage for an off-label medication dosage

Using published evidence and compendia to support expanded coverage for an off-label medication dosage

A pharma company needed to evaluate the likelihood that drug compendia would positively rate an off-label dosage of an FDA-approved medication to support additional payer coverage.

Read More Using published evidence and compendia to support expanded coverage for an off-label medication dosageContinue

Pricing an oral formulation for a bioequivalent COPD product

Pricing an oral formulation for a bioequivalent COPD product

A biopharma company needed an appropriate pricing model for a new tablet formulation of a successful existing infusion.

Read More Pricing an oral formulation for a bioequivalent COPD productContinue

Page navigation

Previous PagePrevious 1 2 3
Magnolia market access, a medical knowledge group company
  • 400 Crossing Blvd, 1st Floor
    Bridgewater, NJ 08807
  • (212) 404-7622
  • [email protected]
  • Our Expertise
  • Our Work
  • Meet the Team
  • Meet MKG
  • Terms of Use
  • Privacy Policy
  • Sitemap
© 2026 Magnolia Market Access
Scroll to top
  • Our Expertise
    • Policy & Access
    • Pricing & Value
    • RWE & HEOR
    • Commercialization & Analytics
  • Our Work
    • Insights
    • Events
    • Market Access Briefs
  • Meet Our Team
  • Meet MKG
Contact Us